Published in Blood Weekly, August 19th, 1996
Previous studies have shown that intravenous infusions of IL-2, given in the right dose for the right amount of time, can restore depleted CD4 counts in patients with HIV disease.
New studies now show that IL-2 taken on an outpatient basis, in combination with antiretroviral therapy, can have similar effects.
"While clinical significance of these findings remains to be established, it has not escaped our notice that the subcutaneous administration of IL-2 and antiretroviral therapy has the potential to maintain...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1996-08-19)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.